SEC Form 4 · accession 0001127602-15-016627
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Massaro
Director
Period of report
May 6, 2015
Accepted (ET)
May 8, 2015 · 7:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 6, 2015 | A | 1,970 | $0.00 | A | 16,480 | D | |
| Common Stock | May 7, 2015 | S | 160 | $69.98 | D | 16,320 | D | |
| Common Stock | May 7, 2015 | S | 100 | $69.99 | D | 16,220 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.04 | D | 16,120 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.10 | D | 16,020 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.12 | D | 15,920 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.17 | D | 15,820 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.23 | D | 15,720 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.25 | D | 15,620 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.29 | D | 15,520 | D | |
| Common Stock | May 7, 2015 | S | 200 | $70.35 | D | 15,320 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.45 | D | 15,220 | D | |
| Common Stock | May 7, 2015 | S | 100 | $70.56 | D | 15,120 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F3 | $70.29 | May 6, 2015 | A | 3,140 | A | May 6, 2016 | May 6, 2020 | Common Stock | 3,140 | 3,140 | D |
Explanation of responses
- F1The Restricted Shares of Common Stock vest upon the earlier of 5/6/2016 or the business day prior to the Company's next annual meeting of shareholders.
- F2This sale occurred pursuant to a 10b5-1 Trading Plan.
- F3The Stock Options become exercisable upon the earlier of 5/6/2016 or the business day prior to the Company's next annual meeting of shareholders.